» Articles » PMID: 28283373

Dynamics Affecting the Risk of Silent Circulation when Oral Polio Vaccination is Stopped

Overview
Journal Epidemics
Publisher Elsevier
Date 2017 Mar 12
PMID 28283373
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Waning immunity could allow transmission of polioviruses without causing poliomyelitis by promoting silent circulation (SC). Undetected SC when oral polio vaccine (OPV) use is stopped could cause difficult to control epidemics. Little is known about waning. To develop theory about what generates SC, we modeled a range of waning patterns. We varied both OPV and wild polio virus (WPV) transmissibility, the time from beginning vaccination to reaching low polio levels, and the infection to paralysis ratio (IPR). There was longer SC when waning continued over time rather than stopping after a few years, when WPV transmissibility was higher or OPV transmissibility was lower, and when the IPR was higher. These interacted in a way that makes recent emergence of prolonged SC a possibility. As the time to reach low infection levels increased, vaccine rates needed to eliminate polio increased and a threshold was passed where prolonged low-level SC emerged. These phenomena were caused by increased contributions to the force of infection from reinfections. The resulting SC occurs at low levels that would be difficult to detect using environmental surveillance. For all waning patterns, modest levels of vaccination of adults shortened SC. Previous modeling studies may have missed these phenomena because (1) they used models with no or very short duration waning and (2) they fit models to paralytic polio case counts. Our analyses show that polio case counts cannot predict SC because nearly identical polio case count patterns can be generated by a range of waning patterns that generate different patterns of SC. We conclude that the possibility of prolonged SC is real but unquantified, that vaccinating modest fractions of adults could reduce SC risk, and that joint analysis of acute flaccid paralysis and environmental surveillance data can help assess SC risks and ensure low risks before stopping OPV.

Citing Articles

Outbreak Response to Circulating Vaccine-Derived Poliovirus in Three Northern Regions of Ghana, 2019.

Odoom J, Dzotse E, Nii-Trebi N, Opare D, Akyereko E, Attiku K Biomed Res Int. 2024; 2024:5515777.

PMID: 39399343 PMC: 11469924. DOI: 10.1155/2024/5515777.


Prior exposure to pathogens augments host heterogeneity in susceptibility and has key epidemiological consequences.

Hawley D, Perez-Umphrey A, Adelman J, Fleming-Davies A, Garrett-Larsen J, Geary S PLoS Pathog. 2024; 20(9):e1012092.

PMID: 39231171 PMC: 11404847. DOI: 10.1371/journal.ppat.1012092.


Prior exposure to pathogens augments host heterogeneity in susceptibility and has key epidemiological consequences.

Hawley D, Perez-Umphrey A, Adelman J, Fleming-Davies A, Garrett-Larsen J, Geary S bioRxiv. 2024; .

PMID: 38496428 PMC: 10942282. DOI: 10.1101/2024.03.05.583455.


Complexity of options related to restarting oral poliovirus vaccine (OPV) in national immunization programs after OPV cessation.

Kalkowska D, Wassilak S, Wiesen E, Estivariz C, Burns C, Badizadegan K Gates Open Res. 2023; 7:55.

PMID: 37547300 PMC: 10403636. DOI: 10.12688/gatesopenres.14511.1.


Effect of Population Partitioning on the Probability of Silent Circulation of Poliovirus.

Vallejo C, Pearson C, Koopman J, Hladish T Bull Math Biol. 2022; 84(6):62.

PMID: 35507206 PMC: 9482762. DOI: 10.1007/s11538-022-01014-6.


References
1.
Manor Y, Shulman L, Kaliner E, Hindiyeh M, Ram D, Sofer D . Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013. Euro Surveill. 2014; 19(7):20708. DOI: 10.2807/1560-7917.es2014.19.7.20708. View

2.
Tebbens R, Pallansch M, Wassilak S, Cochi S, Thompson K . Combinations of Quality and Frequency of Immunization Activities to Stop and Prevent Poliovirus Transmission in the High-Risk Area of Northwest Nigeria. PLoS One. 2015; 10(6):e0130123. PMC: 4465973. DOI: 10.1371/journal.pone.0130123. View

3.
Behrend M, Hu H, Nigmatulina K, Eckhoff P . A quantitative survey of the literature on poliovirus infection and immunity. Int J Infect Dis. 2013; 18:4-13. DOI: 10.1016/j.ijid.2013.09.005. View

4.
Thompson K, Pallansch M, Tebbens R, Wassilak S, Kim J, Cochi S . Preeradication vaccine policy options for poliovirus infection and disease control. Risk Anal. 2013; 33(4):516-43. PMC: 7941951. DOI: 10.1111/risa.12019. View

5.
Debanne S, Rowland D . Statistical certification of eradication of poliomyelitis in the Americas. Math Biosci. 1998; 150(1):83-103. DOI: 10.1016/s0025-5564(98)00007-8. View